Picture of Newron Pharmaceuticals SpA logo

NWRN — Newron Pharmaceuticals SpA News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Swiss stocks - Factors to watch on Dec 26

ZURICH, Dec 26 (Reuters) - The following are some of the 
main factors expected to affect Swiss stocks on Monday. 
     
    ACTELION  ATLN.S  
    The SIX Swiss Exchange said U.S. hedge fund founder Dan Och, 
of Och-Ziff Capital Management Group  OZM.N , through a variety 
of investment vehicles holds more than 3.1 percent of shares in 
Swiss biotech Actelion that is being courted by possible buyers 
including Johnson & Johnson  JNJ.N . 
    For more click  ATLN.S  
     
    LEONTEQ  LEON.S  
    Newspaper Schweiz am Sonntag reported Leonteq founder and 
CEO Jan Schoch's online bank for millionaires, Flynt, might have 
flopped before it ever got started, with its two main proponents 
having jumped ship, the launch date postponed and licensing 
challe nges with FINMA. Schoch remains Leonteq's second-biggest 
shareholder, according to Reuters data. 
    For more click  LEON.S  
     
    GALENICA  GALN.S  
    SonntagsZeitung reported it is possible that its name change 
to Vifor Pharma and the float of its pharmacy business Galenica 
Sante on the stock exchange will take place in the first half of 
2017, citing an interview with Chairman Etienne Jornod. With the 
proceeds from the share sale, Vifor will be able to refinance 
the 1.6 billion Swiss franc acquisition of U.S.-based Relypsa 
without having to resort to a capital increase, the paper 
reported. 
    For more click  GALN.S  
       
    COMPANY STATEMENTS  CPR-CH  
    * Newron Pharmaceuticals  NWRN.S  said Dennis Dionne, 
Executive Director for Commercial Operations since 2015, has 
been appointed to the Company's Senior Management Team as Vice 
President Commercial Affairs, effective January 1, 2017. He will 
replace Anders Haegerstrand, who is leaving the company. 
 NWRN.S   
     
    ECONOMY  M-CH  
     
 
 (Reporting by Zurich newsroom) 
 ((+41 58 306 7336)(zurich.newsroom@thomsonreuters.com)) 
  
((For Top News in a multimedia Web format on Eikon visit: 
https://emea1.views.cp.extranet.thomsonreuters.biz/Explorer/NEWSxTOPNEWS.aspx?group=SP_GROUP_001&page=SP_PAGE_001&pageName=FrontPage 
 FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON: 
     
 Daily Swiss stock market report in German................ .SDE  
 All SMI constituent stocks............................ 0#.SSMI   
 News on major Swiss stock price moves.................. CH-HOT  
 FTSE Eurotop 300 index................................  .FTEU3  
 DJ STOXX index........................................  .STOXX  
 Top 10 STOXX sectors.............................  .PGL.STOXXS   
 Top 10 EUROSTOXX sectors........................  .PGL.STOXXES  
 Top 10 Eurotop 300 sectors.......................  .PGL.FTEU3S  
 Top 25 European pct gainers...  .PG.PEUR , losers...  .PL.PEUR  
     
 Swiss mid-cap index      .SSMI   SMI futures            0#SMI:  
 Swiss all-share index    .SSHI   Market statistics   CH/STATS1  
 Swiss market digest      .AD.S   Sector overview    CH/SECTOR1  
 All Swiss news              CH   Swiss research news     CH-RCH    
 All equity news              E   
      
 INTERNET ADDRESSES:               
  
Swiss Exchange  www.swx.ch/      
Eurex   www.eurexchange.com 
STOXX Ltd         www.stoxx.com  
  
 SPEED GUIDES:  VX/EQUITY   EQUITY   EQUITY/NEWS1   EUR/EQUITY   
  SWITZERLAND   REUTERS  )) 
 
Keywords: MARKETS SWISS STOCKS/

Recent news on Newron Pharmaceuticals SpA

See all news